Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Keck

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Transplantation Proceedings|February 1, 1995
Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trialH P Lemmens, J M Langrehr, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantationJ Klupp, M Glanemann, W O Bechstein, et al.
Transplantation Proceedings|February 1, 1993
Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapyB Neuhaus, H Keck, W O Bechstein, et al.
Fortschritte Der Medizin|March 30, 1993
[Liver transplantation as a routine procedure? Indications and results in 270 patients]J M Langrehr, G Blumhardt, W O Bechstein, et al.
Transplantation Proceedings|February 1, 1995
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxisJ M Langrehr, H P Lemmens, H Keck, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Mycophenolate mofetil added to immunosuppression after liver transplantation--first resultsJ Klupp, W O Bechstein, K P Platz, et al.
Zeitschrift Fur Arztliche Fortbildung|April 1, 1994
[Living with a liver transplant--indications, prognosis and quality of life]J M Langrehr, H Keck, W O Bechstein, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Radiology|March 1, 1996
Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesionsT J Vogl, R Hammerstingl, W Schwarz, et al.
Transplantation Proceedings|September 2, 1998
Incidence and risk factors of prolonged mechanical ventilation and causes of reintubation after liver transplantationM Glanemann, J M Langrehr, A R Müller, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Transplantation Proceedings|February 1, 1995
Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trialH P Lemmens, J M Langrehr, W O Bechstein, et al.
Transplantation Proceedings|March 20, 1999
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantationJ Klupp, M Glanemann, W O Bechstein, et al.
Transplantation Proceedings|February 1, 1993
Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapyB Neuhaus, H Keck, W O Bechstein, et al.
Fortschritte Der Medizin|March 30, 1993
[Liver transplantation as a routine procedure? Indications and results in 270 patients]J M Langrehr, G Blumhardt, W O Bechstein, et al.
Transplantation Proceedings|February 1, 1995
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxisJ M Langrehr, H P Lemmens, H Keck, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Mycophenolate mofetil added to immunosuppression after liver transplantation--first resultsJ Klupp, W O Bechstein, K P Platz, et al.
Zeitschrift Fur Arztliche Fortbildung|April 1, 1994
[Living with a liver transplant--indications, prognosis and quality of life]J M Langrehr, H Keck, W O Bechstein, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Radiology|March 1, 1996
Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesionsT J Vogl, R Hammerstingl, W Schwarz, et al.
Transplantation Proceedings|September 2, 1998
Incidence and risk factors of prolonged mechanical ventilation and causes of reintubation after liver transplantationM Glanemann, J M Langrehr, A R Müller, et al.
Pageof 9